Galaxy Surfactants Q2 Results Review - Robust Overall Volumes Led By Growth Across Markets: Motilal Oswal

Motilal Oswal Report

The continued focus on research and development (with an annual expenditure of Rs 400-500 million) and increased wallet share from its existing customers should drive volume growth. Margin is also expected to expand gradually.

We estimate a volume compound annual growth rate of Galaxy Surfactants Ltd. is 9% over FY23-25, led by robust volumes in the domestic market and a recovery in the specialty care products volumes in the developed markets, which have already started showing signs of growth.

The stock is currently trading at ~26 times FY25E earning per share of Rs 112.7 and ~16 times FY25E enterprise value/Ebitda.

We value the Galaxy Surfactants at 30 times FY25E earning per share to arrive at a target price of Rs 3,380. We reiterate our 'Buy' rating on the stock.

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.